MICROVASCULAR COMPLICATIONS — RETINOPATHY ( JK SUN AND PS SILVA
暂无分享,去创建一个
M. DeAngelis | N. Haider | A. M. Olivares | Kristen Althoff | Siqi Wu | Margaux A. Morrisson | Gloria F Chen
[1] Hong Wang,et al. Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[2] Long Jin,et al. Jiangtang Xiaozhi Recipe (降糖消脂方) prevents diabetic retinopathy in streptozotocin-induced diabetic rats , 2017, Chinese Journal of Integrative Medicine.
[3] R. Wilensky,et al. Retinal pathology is associated with increased blood–retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA2 inhibitor Darapladib , 2017, Diabetes & vascular disease research.
[4] Lianhong Pi,et al. Effects of microRNA-29a on retinopathy of prematurity by targeting AGT in a mouse model. , 2017, American journal of translational research.
[5] Yixue Li,et al. Comparative Genome of GK and Wistar Rats Reveals Genetic Basis of Type 2 Diabetes , 2015, PloS one.
[6] M. Brock,et al. Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] Paul G McMenamin,et al. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice. , 2015, Experimental eye research.
[8] P. Lu,et al. Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization , 2015, Current eye research.
[9] L. Balmer,et al. Characterization of Retinal Vascular and Neural Damage in a Novel Model of Diabetic Retinopathy. , 2015, Investigative ophthalmology & visual science.
[10] M. Ulbig,et al. Diabetic retinopathy - ocular complications of diabetes mellitus. , 2015, World journal of diabetes.
[11] L. Gnudi,et al. Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] E. Rakoczy,et al. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. , 2014, Experimental eye research.
[13] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[14] C. Eleazu,et al. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans , 2013, Journal of Diabetes & Metabolic Disorders.
[15] M. Mishra,et al. Epigenetic Modifications and Diabetic Retinopathy , 2013, BioMed research international.
[16] A. C. Lo,et al. Animal Models of Diabetic Retinopathy: Summary and Comparison , 2013, Journal of diabetes research.
[17] Chang Sik Cho,et al. Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics , 2013, Journal of Biomedical Science.
[18] N J Cox,et al. Genome wide association studies for diabetes: perspective on results and challenges , 2013, Pediatric diabetes.
[19] M. Sarras,et al. A zebrafish model of diabetes mellitus and metabolic memory. , 2013, Journal of visualized experiments : JoVE.
[20] S. Seino,et al. A Novel Rat Model of Type 2 Diabetes: The Zucker Fatty Diabetes Mellitus ZFDM Rat , 2013, Journal of diabetes research.
[21] Shannon M. Conley,et al. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy. , 2013, Investigative ophthalmology & visual science.
[22] Yingbin Ge,et al. Tacrolimus (FK506) prevents early retinal neovascularization in streptozotocin-induced diabetic mice. , 2012, International immunopharmacology.
[23] T. Wong,et al. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals , 2012, Disease Models & Mechanisms.
[24] C. Jobin,et al. Think Small: Zebrafish as a Model System of Human Pathology , 2012, Journal of biomedicine & biotechnology.
[25] I. Ember,et al. Retinal and renal vascular permeability changes caused by stem cell stimulation in alloxan-induced diabetic rats, measured by extravasation of fluorescein. , 2012, In vivo.
[26] Sunil K. Sharma,et al. Acute and chronic animal models for the evaluation of anti-diabetic agents , 2012, Cardiovascular Diabetology.
[27] S. Cartner,et al. The influence of alloxan-induced diabetes on Müller cell contraction-promoting activities in vitreous. , 2011, Investigative ophthalmology & visual science.
[28] D. Medeiros,et al. Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes , 2011, Experimental biology and medicine.
[29] Kyu-Won Kim,et al. Investigation of barrier characteristics in the hyaloid‐retinal vessel of zebrafish , 2011, Journal of neuroscience research.
[30] A. Goldberg,et al. Mitochondrial biogenesis and the development of diabetic retinopathy. , 2011, Free radical biology & medicine.
[31] Francisco A H Fonseca,et al. Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits , 2011, International journal of experimental pathology.
[32] Hans E. Grossniklaus,et al. Animal models of choroidal and retinal neovascularization , 2010, Progress in Retinal and Eye Research.
[33] J. Sowers,et al. Retinal Redox Stress and Remodeling in Cardiometabolic Syndrome and Diabetes , 2010, Oxidative medicine and cellular longevity.
[34] J. Steffensen,et al. Hypoxia-induced retinopathy model in adult zebrafish , 2010, Nature Protocols.
[35] E. Rakoczy,et al. Characterization of a mouse model of hyperglycemia and retinal neovascularization. , 2010, The American journal of pathology.
[36] L. Zhuo,et al. Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model. , 2010, Experimental eye research.
[37] M. Sarras,et al. Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus , 2010, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[38] F. V. van Eeden,et al. von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish , 2010, Disease Models & Mechanisms.
[39] V. D’Agati,et al. Ultrastructural Features of Retinal Capillary Basement Membrane Thickening in Diabetic Swine , 2010, Ultrastructural pathology.
[40] T. Sasase,et al. Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat , 2009, Diabetes, obesity & metabolism.
[41] S. Bonner-Weir,et al. Towards better understanding of the contributions of overwork and glucotoxicity to the β‐cell inadequacy of type 2 diabetes , 2009, Diabetes, obesity & metabolism.
[42] T. Matsuura,et al. Diabetic retinopathy and choroidal angiopathy in diabetic rats (WBN/Kob). , 2009, Experimental animals.
[43] A. Joussen,et al. TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations , 2009, Molecular vision.
[44] J. Blay,et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. , 2009, Cancer research.
[45] Guohong Zhang,et al. Hereditary pancreatitis model WBN/Kob rat strain has a unique haplotype in the Pdwk1 region on chromosome 7. , 2009, Experimental animals.
[46] Å. Lernmark,et al. Sequence Variation and Expression of the Gimap Gene Family in the BB Rat , 2009, Experimental diabetes research.
[47] Andrew D. Paterson,et al. Type 1 Diabetes in the BB Rat: A Polygenic Disease , 2009, Diabetes.
[48] A. Vingrys,et al. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen‐induced retinopathy , 2008, Glia.
[49] S. Madsen-Bouterse,et al. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives , 2008, Reviews in Endocrine and Metabolic Disorders.
[50] Yihai Cao,et al. Hypoxia-Induced Retinal Angiogenesis in Zebrafish as a Model to Study Retinopathy , 2008, PloS one.
[51] N. Harris,et al. Losartan and Ozagrel Reverse Retinal Arteriolar Constriction in Non‐Obese Diabetic Mice , 2008, Microcirculation.
[52] E. Rakoczy,et al. VEGF-induced choroidal damage in a murine model of retinal neovascularisation , 2008, British Journal of Ophthalmology.
[53] Allen R Kunselman,et al. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.
[54] S. Schellini,et al. Temporal relationship between successful pancreas transplantation and control of ocular complications in alloxan-induced diabetic rats. , 2007, Transplantation proceedings.
[55] Wei Dai,et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. , 2008, Investigative ophthalmology & visual science.
[56] A. Vingrys,et al. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity , 2007, The Journal of comparative neurology.
[57] M. Gleeson,et al. Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina , 2007, Acta Diabetologica.
[58] M. Matsumura,et al. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy , 2007, Molecular vision.
[59] J. Sahel,et al. Microglial changes occur without neural cell death in diabetic retinopathy , 2007, Vision Research.
[60] H. Tamemoto,et al. Characteristics of diabetic retinopathy in SDT rats , 2006, Diabetes/metabolism research and reviews.
[61] E. Rakoczy,et al. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. , 2006, Investigative ophthalmology & visual science.
[62] A. Barber,et al. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. , 2006, Investigative ophthalmology & visual science.
[63] J. Reichen,et al. Endothelin Antagonism Prevents Diabetic Retinopathy in NOD Mice: A Potential Role of the Angiogenic Factor Adrenomedullin , 2006, Experimental biology and medicine.
[64] D. Guidolin,et al. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model , 2006, Diabetologia.
[65] R. Klein,et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. , 2006, American journal of ophthalmology.
[66] S. Chung,et al. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. , 2005, Diabetes.
[67] D. Chen,et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. , 2005, Investigative ophthalmology & visual science.
[68] M. Matsumura,et al. Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat , 2005, Diabetologia.
[69] T. Gardner,et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. , 2005, Investigative ophthalmology & visual science.
[70] H. Hishigaki,et al. MUTATED G‐PROTEIN‐COUPLED RECEPTOR GPR10 IS RESPONSIBLE FOR THE HYPERPHAGIA/DYSLIPIDAEMIA/OBESITY LOCUS OF Dmo1 IN THE OLETF RAT , 2005, Clinical and experimental pharmacology & physiology.
[71] H. Brereton,et al. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat. , 2005, Investigative ophthalmology & visual science.
[72] Ulrich Schraermeyer,et al. A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[73] V. Ganapathy,et al. Death of retinal neurons in streptozotocin-induced diabetic mice. , 2004, Investigative ophthalmology & visual science.
[74] H. Schulze-Koops. Lymphopenia and autoimmune diseases , 2004, Arthritis research & therapy.
[75] F. Ferris,et al. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs. , 2003, Archives of ophthalmology.
[76] R. Maki,et al. Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice , 2003, The Journal of Immunology.
[77] R. Schmidt,et al. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy. , 2003, The American journal of pathology.
[78] H. Tsujii,et al. Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat. , 2003, Biochemical and biophysical research communications.
[79] D. Severson,et al. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. , 2003, Diabetes.
[80] P. Halban,et al. Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. , 2003, Diabetes.
[81] M. Sturek,et al. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. , 2002, Comparative medicine.
[82] Eric S Lander,et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. , 2002, Genome research.
[83] T. Amemiya,et al. Retinal and Choroidal Vasculature in Rats with Spontaneous Diabetes Type 2 Treated with the Angiotensin-Converting Enzyme Inhibitor Cilazapril: Corrosion Cast and Electron-Microscopic Study , 2002, Ophthalmic Research.
[84] J. Rømer,et al. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. , 2002, Diabetes.
[85] J. Tang,et al. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. , 2001, Diabetes.
[86] I. Nishimori,et al. Quantitative trait locus analysis for chronic pancreatitis and diabetes mellitus in the WBN/Kob rat. , 2001, Genomics.
[87] J. Dimsdale,et al. Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. , 2001, Life sciences.
[88] J. Cunha-Vaz,et al. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. , 2000, Nitric oxide : biology and chemistry.
[89] D. Severson,et al. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.
[90] P. Leuenberger,et al. Glial reactivity, an early feature of diabetic retinopathy. , 2000, Investigative ophthalmology & visual science.
[91] T. Amemiya,et al. Retinal Capillary Changes in Otsuka Long-Evans Tokushima Fatty Rats (Spontaneously Diabetic Strain) , 1999, Ophthalmic Research.
[92] K Miyamoto,et al. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. , 1998, Investigative ophthalmology & visual science.
[93] R. Linsenmeier,et al. Retinal hypoxia in long-term diabetic cats. , 1998, Investigative ophthalmology & visual science.
[94] F. Drago,et al. Effects of sulfinpyrazone on retinal damage induced by experimental diabetes mellitus in rabbits. , 1998, Pharmacological research.
[95] T. Amemiya,et al. Lens and Retinal Changes in the WBN/Kob Rat (Spontaneously Diabetic Strain) , 1998, Ophthalmic Research.
[96] E. Kubo,et al. Retinal vessel changes in galactose-fed dogs. , 1998, Archives of ophthalmology.
[97] P. Campochiaro,et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.
[98] E. Agardh,et al. Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina. , 1997, Journal of diabetes and its complications.
[99] E. Leiter,et al. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. , 1997, Journal of immunology.
[100] T. Kern,et al. A mouse model of diabetic retinopathy. , 1996, Archives of ophthalmology.
[101] G. Papaccio. Non-obese diabetic (NOD) mouse. , 1996, The American journal of pathology.
[102] Y. Ogura,et al. Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes. , 1996, Investigative ophthalmology & visual science.
[103] L. Tartaglia,et al. Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.
[104] A. Cooke,et al. The genetics of the NOD mouse. , 1995, Diabetes/metabolism reviews.
[105] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[106] J. Stone,et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[107] T. Kern,et al. Retinopathy in animal models of diabetes. , 1995, Diabetes/metabolism reviews.
[108] C. Toth,et al. Diabetic retinopathy in a cat. , 1995, Experimental eye research.
[109] J. Penn,et al. Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat , 1994, Pediatric Research.
[110] Joan W. Miller,et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.
[111] Alan W. Stitt,et al. Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. , 1994, The British journal of ophthalmology.
[112] Alan W. Stitt,et al. Induction of alloxan/streptozotocin diabetes in dogs: A revised experimental technique , 1993, Laboratory animals.
[113] R. Danis,et al. Microvascular retinopathy in the Zucker diabetic fatty rat. , 1993, Investigative ophthalmology & visual science.
[114] G. Schmid-Schönbein,et al. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.
[115] D. Hatchell,et al. Reduction of basement membrane thickening in diabetic cat retina by sulindac. , 1990, Investigative ophthalmology & visual science.
[116] M. K. Kim,et al. Genetic Control of Organ-Reactive Autoantibody Production in Mice by Obesity (ob) Diabetes (db) Genes , 1988, Diabetes.
[117] D. Hatchell,et al. Experimental diabetes in cats induced by partial pancreatectomy alone or combined with local injection of alloxan. , 1987, Laboratory animal science.
[118] T. Kern,et al. Experimental Galactosemia Produces Diabetic-like Retinopathy , 1984, Diabetes.
[119] Y. Tochino,et al. Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.
[120] D. Coleman,et al. Endocrine pancreatic cells of postatal “diabetes” (DB) mice in cell culture , 1979, In Vitro.
[121] C. Bulpitt,et al. Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. , 1969, Investigative ophthalmology.
[122] R. Engerman,et al. EXPERIMENTAL DIABETIC RETINOPATHY IN DOGS. , 1965, Archives of ophthalmology.
[123] N. Rakieten,et al. Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.
[124] R. Crane. An effect of alloxan-diabetes on the active transport of sugars by rat small intestine, in vitro. , 1961, Biochemical and biophysical research communications.
[125] S. Weinhouse,et al. Hepatic glucokinase in the fed, fasted, and alloxan-diabetic rat. , 1960, The Journal of biological chemistry.
[126] T. Malinin,et al. PROTEIN IN DYING β-CELLS OF THE PANCREATIC ISLETS , 1960 .
[127] C. Best. The internal secretion of the pancreas. , 1922, Canadian Medical Association journal.
[128] L. Wen,et al. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. , 2016, Journal of autoimmunity.
[129] S. Yarkoni,et al. Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells , 2013, Immunologic Research.
[130] K. Dahlman-Wright,et al. The diversity of sex steroid action: regulation of metabolism by estrogen signaling. , 2012, The Journal of endocrinology.
[131] Cai-Rui Li,et al. VEGF expression and cell apoptosis in NOD mouse retina. , 2010, International journal of ophthalmology.
[132] Makoto Nakamura,et al. Altered expression of aquaporins 1 and 4 coincides with neurodegenerative events in retinas of spontaneously diabetic Torii rats. , 2010, Experimental eye research.
[133] R. Klein,et al. The Role of Genetics in Susceptibility to Diabetic Retinopathy , 2009, International ophthalmology clinics.
[134] J. Cunha-Vaz. Characterization and relevance of different diabetic retinopathy phenotypes. , 2007, Developments in ophthalmology.
[135] T. Amemiya,et al. Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat)--possibility of a new experimental model for diabetic retinopathy. , 2003, Japanese journal of ophthalmology.
[136] N. McLetchie. Alloxan diabetes: a discovery, albeit a minor one. , 2002, The journal of the Royal College of Physicians of Edinburgh.
[137] A. Kakehashi,et al. A New Spontaneously Diabetic Non-obese Torii Rat Strain With Severe Ocular Complications , 2000, International journal of experimental diabetes research.
[138] R. Hansen,et al. Rod photoreceptors in infant rats with a history of oxygen exposure. , 1999, Investigative ophthalmology & visual science.
[139] Danhong Lu,et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.
[140] R. Clements,et al. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. , 1998, Journal of diabetes and its complications.
[141] F. Ferris,et al. Diabeteslike proliferative retinal changes in galactose-fed dogs. , 1995, Archives of ophthalmology.
[142] T. Kern,et al. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. , 1994, Current eye research.
[143] E. Leiter. The NOD Mouse: A Model for Analyzing the Interplay Between Heredity and Environment in Development of Autoimmune Disease , 1993 .
[144] R. Klein,et al. Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? , 1993, Annals of epidemiology.
[145] O. Jonasson,et al. Microangiopathic retinopathy in experimental diabetic monkeys. , 1988, Transactions of the American Ophthalmological Society.
[146] M. Sasaki,et al. Development of diabetes in the non-obese NIDDM rat (GK rat). , 1988, Advances in experimental medicine and biology.
[147] S. Chakrabarti,et al. The BB-rat--an authentic model of human diabetic retinopathy. , 1985, Current eye research.
[148] Streptozotocin* , 1981 .
[149] Y. Gotō,et al. Spontaneous Diabetes Produced by Selective Breeding of Normal Wistar Rats , 1975 .